Evaluation of the Expression EGFR, HER2/NEU and the End Effector ERK of the RAS/RAF/MAP Kinase Pathway in Prostatic Adenocarcinoma for a Possible Role as New Target Therapy
评估前列腺腺癌中 EGFR、HER2/NEU 和 RAS/RAF/MAP 激酶通路末端效应子 ERK 的表达作为新靶向治疗的可能作用
期刊:Asian Pacific Journal of Cancer Prevention
影响因子:
doi:10.31557/APJCP.2024.25.6.2193
Asem Shalaby, Heba A Mahmoud, Shayma G Sayed, Khalid Al Hashmi, Shadia Al-Sinawi, Suad Al Badi, Afrah Al Rashdi, Samya Al Husaini, Hajer Al Badi, Somaia Ahmed Saad El-Din
